About Kashiv BioSciences
Kashiv BioSciences is a company based in Piscataway (United States) founded in 2010 by Chintu Patel and Chirag Patel was acquired by Amneal in April 2026. The company has 164 employees as of April 04, 2024.
- Headquarter Piscataway, United States
- Employees 164 as on 04 Apr, 2024
- Founders Chintu Patel, Chirag Patel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kashiv Biosciences Private Limited
- Date of Incorporation 29 Jun, 2018
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$14.68 M (USD)114.45as on Mar 31, 2023
-
Net Profit
$1.66 M (USD)112.65as on Mar 31, 2023
-
EBITDA
$3.71 M (USD)113.8as on Mar 31, 2023
-
Latest Funding Round
$72.29 M (USD), Debt – Conventional
Dec 22, 2025
- Investors
-
Employee Count
164
as on Apr 04, 2024
-
Acquired by
Amneal
(Apr 22, 2026)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Kashiv BioSciences
Unlock access to complete
Funding Insights of Kashiv BioSciences
Investors in Kashiv BioSciences
Kashiv BioSciences has secured backing from 1 investor. Prominent investors backing the company include Amneal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of generics formulations
|
Locked | Locked | Locked |
Investor details for Kashiv BioSciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kashiv BioSciences
Investment portfolio details for Kashiv BioSciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kashiv BioSciences
Detailed financials for Kashiv BioSciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kashiv Biosciences Comparisons
Peer comparison for Kashiv BioSciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kashiv BioSciences
Detailed competitors of Kashiv BioSciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kashiv Biosciences
Complete news archive for Kashiv BioSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kashiv BioSciences
Kashiv BioSciences was founded in 2010 and raised its 1st funding round 15 years after it was founded.
Kashiv BioSciences is headquartered in Piscataway, United States. It is registered at Piscataway, New Jersey, United States.
Sandeep Athalye is the current CEO of Kashiv BioSciences.
As of Apr 04, 2024, the latest employee count at Kashiv BioSciences is 164.
Annual revenue of Kashiv BioSciences is $14.68M as on Mar 31, 2023.
Kashiv BioSciences was established in 2010 and is headquartered in Piscataway, United States. As an integrated biopharmaceutical company, focus is placed on developing biosimilar medicines. Capabilities encompass research and development, clinical operations, manufacturing processes, regulatory compliance, and intellectual property management. Operations support the creation of affordable alternatives to biologic drugs within the healthcare sector.
Kashiv BioSciences has 1 investor. Key investors include Amneal.